3-iodobenzylguanidine has been researched along with Soft Tissue Neoplasms in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (16.67) | 18.7374 |
1990's | 4 (33.33) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McHugh, K; Orr, KE | 1 |
Bagatell, R; Berthold, F; Boubaker, A; Brock, P; Burchill, S; Cohn, SL; Ladenstein, R; Lindwasser, OW; London, WB; Maris, JM; Matthay, KK; McHugh, K; Nuchtern, JG; Park, JR; Pearson, AD; Schleiermacher, G; Seibel, NL; Valteau-Couanet, D; Villablanca, JG | 1 |
Servaes, SE; Tolboom, N; Zhuang, H | 1 |
Cohn, SL; Giammarile, F; Ladenstein, R; Lewington, V; Matthay, KK; Michon, J; Pearson, AD; Shulkin, B | 1 |
Howman-Giles, R; Shaw, PJ; Uren, RF | 1 |
Cheung, NK; Kramer, K; Kushner, BH; Larson, SM; Yeung, HW | 1 |
Bares, R; Geiger, L; Haase, B; Handgretinger, R; Müller-Schauenburg, W; Niethammer, D; Reuland, P; Thelen, MH | 1 |
Hutchinson, RJ; Shapiro, B; Shulkin, BL | 1 |
Hattner, RS; Huberty, JP; Matthay, KK; Parisi, MT | 1 |
Aubert, B; Brendel, AJ; Carpentier, P; Delisle, MJ; Fleury-Goyon, MC; Gibold, C; Krempf, M; Lumbroso, J; Mornex, R; Wemeau, JL | 1 |
Clarke, SE; Lazarus, CR; Maisey, MN | 1 |
Adolph, J; Brandeis, WE; Kimmig, B | 1 |
3 review(s) available for 3-iodobenzylguanidine and Soft Tissue Neoplasms
Article | Year |
---|---|
The new international neuroblastoma response criteria.
Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Bone Neoplasms; Child; Humans; Iodine Radioisotopes; Neoplasm, Residual; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms | 2019 |
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Bone Neoplasms; Consensus; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms | 2017 |
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
Topics: 3-Iodobenzylguanidine; Advisory Committees; Bone Neoplasms; Child; Female; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Staging; Neuroblastoma; Practice Guidelines as Topic; Radiation Injuries; Radiographic Image Enhancement; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed, Single-Photon | 2010 |
1 trial(s) available for 3-iodobenzylguanidine and Soft Tissue Neoplasms
Article | Year |
---|---|
Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Pheochromocytoma; Prospective Studies; Radionuclide Imaging; Soft Tissue Neoplasms | 1991 |
8 other study(ies) available for 3-iodobenzylguanidine and Soft Tissue Neoplasms
Article | Year |
---|---|
Neuroblastoma Presenting as Non-MIBG-Avid Widespread Soft Tissue Metastases Without Bone Involvement Revealed by FDG PET/CT Imaging.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2017 |
Thallium-201 scintigraphy in pediatric soft-tissue tumors.
Topics: 3-Iodobenzylguanidine; Child; Female; Gallium Radioisotopes; Hodgkin Disease; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphoma, Non-Hodgkin; Male; Neuroblastoma; Radionuclide Imaging; Rhabdomyosarcoma; Soft Tissue Neoplasms; Thallium Radioisotopes; Wilms Tumor | 1995 |
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroblastoma; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response.
Topics: 3-Iodobenzylguanidine; Adolescent; Antibodies, Monoclonal; Bone Neoplasms; Child; Child, Preschool; False Negative Reactions; Female; Fluorescent Antibody Technique; Follow-Up Studies; Gangliosides; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Fusion Proteins; Soft Tissue Neoplasms; Technetium | 2001 |
Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Marrow Diseases; Bone Neoplasms; Child; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging; Soft Tissue Neoplasms; Technetium Tc 99m Medronate | 1992 |
Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Soft Tissue Neoplasms | 1992 |
Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Evaluation Studies as Topic; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organometallic Compounds; Radionuclide Imaging; Soft Tissue Neoplasms; Succimer; Sulfhydryl Compounds; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms | 1987 |
[Diagnosis and therapy control of neuroblastoma using meta-iodo- benzylguanidine].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Half-Life; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Retroperitoneal Neoplasms; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 1985 |